Sort
50,496 grants matching “lung cancer”
Metabolic Adaptive Responses in Cancer
$412,123David R Plas · University Of Cincinnati · R01 · FY2014 · CA
Functional Image and Molecular Marker to Individualize Adaptive Radiation Dose Es
$412,123Feng-Ming P. Kong · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
Optimizing Treatment Approaches to Lung Cancers Harboring MET Exon 14 mutations
$412,108Eric Collisson · University Of California, San Francisco · R01 · FY2021 · CA
Occupational and Environmental Determinants of Cancer among Women and Minorities
$412,102Laura Beane Freeman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA
Ornithine Aminotransferase Inactivation, a New Approach for Treatment of Cancers
$412,090Richard B Silverman · Northwestern University · R01 · FY2021 · CA
Targeting LKB1-null lung adenocarcinoma with innate immune system
$412,067Wei Zhou · Emory University · R01 · FY2024 · CA
A novel preclinical model of spontaneous metastasis
$412,046Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Kisspeptins in the Airway
$412,041Sathish Venkatachalem · North Dakota State University · R01 · FY2022 · HL
CAREER: Statistical and Geometric Analysis for Tree-Shaped Data
$412,038Megan Owen · Research Foundation Of The City University Of New York (Lehman) · · FY2019 · MPS
ISG15 and Protein ISGylation in Cancer
$412,014Dong-Er Zhang · University Of California, San Diego · R01 · FY2020 · CA
Ethanol Effects on Recovery after Injury
$411,997Elizabeth J Kovacs · Loyola University Chicago · R01 · FY2012 · AA
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma
$411,968Roberto Chiarle · Boston Children'S Hospital · R01 · FY2022 · CA
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma
$411,968Roberto Chiarle · Boston Children'S Hospital · R01 · FY2023 · CA
Modeling tumor-stroma crosstalk in lung cancer to identify targets for therapy
$411,967Stephen Tc Wong · Methodist Hospital Research Institute · U01 · FY2017 · CA
MARIJUANA USE AND THE RISKS OF LUNG AND OTHER CANCERS
$411,966University Of California Los Angeles · R01 · FY2002 · DA
Dysregulations of functional RNA modifications and hexavalent chromium lungcarcinogenesis
$411,955Chengfeng Yang · State University New York Stony Brook · R01 · FY2023 · ES
Dysregulations of functional RNA modifications and hexavalent chromium lungcarcinogenesis
$411,955Chengfeng Yang · State University New York Stony Brook · R01 · FY2025 · ES
Dysregulations of functional RNA modifications and hexavalent chromium lungcarcinogenesis
$411,955Chengfeng Yang · State University New York Stony Brook · R01 · FY2024 · ES
Droplet microfluidic technology for single cell cancer genomics
$411,954Allon Moshe Klein · Harvard Medical School · R33 · FY2017 · CA
Molecular dissection of Lkb1-mediated tumor suppression
$411,941Monte Meier Winslow · Stanford University · R01 · FY2019 · CA
Using Vagal Nerve Stimulation in Conjunction with NRT for Smoking Cessation
$411,939Ryan Thomas Hurt · Mayo Clinic Rochester · R21 · FY2025 · CA
NEUROLOGICAL PARANEOPLASTIC SYNDROMES
$411,928Sloan-Kettering Institute For Cancer Res · R01 · FY2000 · NS
Detecting DICER1: A global partnership to cure pediatric lung cancer
$411,901Kris Ann Pinekenstein Schultz · Children'S Hospitals And Clinics · R37 · FY2020 · CA
A lung cancer symptom assessment and management intervention
$411,755Mary E Cooley · Dana-Farber Cancer Inst · R01 · FY2011 · CA
Targeting Ferroptosis in Lethal RB1 Deficient Prostate Cancer
$411,737Ming Hui Chen · Duke University · R01 · FY2023 · CA